IAFP Posttest & Evaluation

The Brain Trust Podcast Series

Episode 15: Early Diagnosis in the New ADRD Treatment Era

Online Enduring Posttest & Evaluation

Please complete all the required fields BEFORE downloading the certificate.

Part I: Post Test & Evaluation

1. The soon to be available FDA approved disease-modifying treatments for ADRD will require early diagnosis and detection because the treatments are indicated for mild cognitive impairment and early Alzheimer’s disease.*

TrueFalse

2. One feasible adaptation in the process is to refer every person over age 65 to a neurologist for conducting a cognitive assessment*

TrueFalse

How much did your knowledge increase since listening to this podcast CME activity?*

Not at all/my knowledge level stayed the sameSlightlySomewhatVery Much

How much did your skill level increase since listening to this podcast CME activity?*

Not at all / my skill level stayed the sameSlightlySomewhatVery much

Following this CME activity, how will you act to change your practice?*

Implement new information or skills into my practiceSeek additional informationDo nothing, as my practice reflects recommendations based on this activityDo nothing, system barriers prevent me from making changes in my practiceOther

This CME activity included or reflected diversity (e.g. racial/ethnic, gender, sexual orientation or gender identity diversity).*

YesNoNot applicableOther

This activity avoided commercial bias or influence (if no, please use the comment box to provide detailed feedback)*

YesNo

Comments:

Part II: Attestation and Contact Information

By checking the box below, I attest to participating in this CME course in its entirety and will claim 0.50 AMA PRA Category 1 Credit. :*

I have participated in this Course and earned 0.50 AMA PRA Category 1 Credit..

Name*

First NameLast Name

Credentials

Address*

Street Address

Street Address Line 2

CityState / Province

Postal / Zip Code

Email*

example@example.com

Phone Number

Area CodePhone Number